E Clinical Trials Solutions Suite Technologies Market
E Clinical Trials Solutions Suite Technologies Market - Global Industry Assessment & Forecast
#
Pages:
145
2022
Mar - 2022
VMR-1427
Segments Covered
By
Product Clinical Data Management Systems (CDMS), Clinical Trial Management Systems (CTMS), Randomization and Trial Supply Management (RTMS), Electronic Clinical Outcome Assessment (eCOA), Electronic Data Capture (EDC), Electronic Patient-reported Outcomes (ePRO), Clinical Data Integration Platforms
-
By
Delivery Model Web- Based (On-Demand) Model, Licensed Enterprise (On-Premise) Model, Cloud- Based
-
By
Development Phase Phase I, Phase II, Phase III, Phase IV
-
By
End User Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations(CROs), Hospitals/ Healthcare Providers, Medical Device Manufacturers, Academic Research Institutions
-
By
Region North America, Asia Pacific, Europe, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 6991.90 Million |
 Revenue 2030:
|
USD 16456.43 Million |
 Revenue CAGR
(2023 - 2030): |
12.90% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Research Methodology: E Clinical Trials Solutions Suite Technologies Market by Product by Delivery Model by Development Phase by End User by Region - Global Market Assessment, 2021 - 2028
Secondary Research
Primary Research:
Data Triangulation and Market Size Estimations
FAQ
Frequently Asked Question
What is the global demand for E Clinical Trials Solutions Suite Technologies in terms of revenue?
-
The global E Clinical Trials Solutions Suite Technologies valued at USD 6991.90 Million in 2022 and is expected to reach USD 16456.43 Million in 2030 growing at a CAGR of 12.90%.
Which are the prominent players in the market?
-
The prominent players in the market are Oracle Corporation (US), Medidata Solutions Inc. (US), Parexel International Corporation (US), BioClinica Inc. (US), Signant Health (US), Datatrak International Inc. (US), ERT (US), eClinical Solutions Inc. (US), MaxisIT Inc. (US), Bio-Optronics Inc. (US), Merge Healthcare Incorporated (US), and OmniComm Systems Inc. (US)..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 12.90% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the E Clinical Trials Solutions Suite Technologies include
- Advantages of eClinical solutions
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the E Clinical Trials Solutions Suite Technologies in 2022.
